Clinical Trial Update: Neoadjuvant Pembrolizumab With a Watch-and-wait Strategy for dMMR/MSI-H Localized Colon Cancer: PREMICES Study. [Phase 2]

View source ↗

Summary

This clinical trial evaluates using pembrolizumab before surgery (neoadjuvant) with a watch-and-wait approach in patients with localized colon cancer that is dM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: GERCOR - Multidisciplinary Oncology Cooperative Group | Conditions: Colon Cancer | Phase 2 | Status: NOT_YET_RECRUITING